236 articles 4 sections last published 2026-08-31 independent · no sponsored placements

Fund index

XLE

7 articles on this site analyse XLE — 3 of them head-on.

Measured concentration

as of 2026-06-30
24 Holdings (nominal)
9.9 Effective holdings
2.4× Overstatement
75.54% Top 10 weight

XLE reports 24 positions, but the weights make it behave like about 9.9 equally weighted ones. Computed by this site from the fund's SEC Form N-PORT filing — see what this measure does not tell you and the full table.

The same filing says what kind of price those positions carry: 100% of XLE is held at a quoted market price, across 2 issuer countries . Comparisons across every fund are in the valuation table, and what a low share does and does not mean is worth reading before drawing a conclusion from it.

Every filing since 2019

28

Between 2019-09-30 and 2026-06-30, XLE went from behaving like 8.8 equally weighted positions to 9.9 — 13% more, while its top ten went from 76.43% to 75.54% of net assets. Read across the funds on the concentration-over-time table.

PeriodHoldingsEffective Top 10Largest
2026-06-30 24 9.9 75.54% 22.67%
2026-03-31 26 9.3 75.77% 23.77%
2025-12-31 24 9.2 75.63% 23.7%
2025-09-30 26 9.4 76.1% 22.77%
2025-06-30 25 10.3 73.21% 22.85%
2025-03-31 27 9.8 73.83% 23.33%
2024-12-31 25 9.9 74.62% 23.08%
2024-09-30 26 9.8 75.02% 23.34%
2024-06-30 25 9.5 74.73% 23.18%
2024-03-31 26 9.7 76.2% 22.8%
2023-12-31 26 9.6 75.59% 22.4%
2023-09-30 25 9.2 73.92% 23.47%
2023-06-30 26 9.3 73.59% 22.76%
2023-03-31 26 9.1 75% 23.04%
2022-12-31 26 9 74.47% 22.85%
2022-09-30 23 9 75.99% 22.99%
2022-06-30 22 8.4 76.43% 23.98%
2022-03-31 23 8.8 75.4% 22.23%
2021-12-31 24 8.7 75.97% 22.7%
2021-09-30 24 8.9 76.54% 22.67%
2021-06-30 24 8.6 77.02% 23.73%
2021-03-31 25 8.5 77.77% 22.35%
2020-12-31 27 8.3 77.71% 23.1%
2020-09-30 28 8.2 79.06% 22.89%
2020-06-30 28 8.2 78.8% 23.04%
2020-03-31 29 8 79.57% 23.56%
2019-12-31 30 9.1 75.23% 22.32%
2019-09-30 30 8.8 76.43% 22.76%

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

Most often compared against

1

Measures applied to it

8

All articles

7

Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.